Anti-Fragilis 抗体 [EPR5242] (ab109429)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR5242] to Fragilis
- Suitable for: WB, IHC-P
- Reacts with: Human
Related conjugates and formulations
製品の概要
-
製品名
Anti-Fragilis antibody [EPR5242]
Fragilis 一次抗体 製品一覧 -
製品の詳細
Rabbit monoclonal [EPR5242] to Fragilis -
由来種
Rabbit -
特異性
Predicted cross-reactivity with IFITM2 (93% homology) but this has not been tested.
-
アプリケーション
適用あり: WB, IHC-Pmore details
適用なし: Flow Cyt or IP -
種交差性
交差種: Human -
免疫原
Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.
-
ポジティブ・コントロール
- WB: HeLa whole cell lysate (PMID: 21177806), Recombinant Human Fragilis protein. IHC-P: Human kidney tissue. This antibody gave a positive result when used in the following formaldehyde fixed cell lines: HeLa.
-
特記事項
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Stable for 12 months at -20°C. -
バッファー
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 40% Glycerol (glycerin, glycerine), 0.05% BSA, 59% PBS -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
モノクローナル -
クローン名
EPR5242 -
アイソタイプ
IgG -
研究分野
関連製品
-
Alternative Versions
-
Isotype control
-
Positive Controls
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab109429の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB |
1/1000 - 1/10000. Predicted molecular weight: 15 kDa.
|
|
IHC-P |
1/250 - 1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Antigen retrieval is recommended. |
特記事項 |
---|
WB
1/1000 - 1/10000. Predicted molecular weight: 15 kDa. |
IHC-P
1/250 - 1/500. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. Antigen retrieval is recommended. |
ターゲット情報
-
機能
IFN-induced antiviral protein that mediates cellular innate immunity to at least three major human pathogens, namely influenza A H1N1 virus, West Nile virus (WNV), and dengue virus (WNV), by inhibiting the early step(s) of replication. -
配列類似性
Belongs to the CD225 family. -
翻訳後修飾
Palmitoylation on membrane-proximal cysteines controls clustering in membrane compartments and antiviral activity against influenza virus. -
細胞内局在
Cell membrane. - Information by UniProt
-
参照データベース
- Entrez Gene: 10410 Human
- Omim: 605579 Human
- SwissProt: Q01628 Human
- Unigene: 374650 Human
-
別名
- 1 8U antibody
- Fragilis antibody
- IFITM3 antibody
see all
画像
-
All lanes : Anti-Fragilis antibody [EPR5242] (ab109429) at 1/1000 dilution
Lane 1 : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 2 : 293T (Human embryonic kidney epithelial cell) whole cell lysate
Lane 3 : HAP1 (Human chronic myelogenous leukemia near-haploid cell line) whole cell lysate
Lane 4 : Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate
Lysates/proteins at 20 µg per lane.
Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution
Developed using the ECL technique.
Predicted band size: 15 kDa
Observed band size: 15 kDa
Exposure time: 1 secondLane 1: Positive control - Hela (PMID: 21177806)
Lanes 2-4: Negative control - 293T and Jurkat (PMID: 21177806) HAP1(PMID: 29079573).
Blocking buffer: 5% NFDM/TBST
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Fragilis antibody [EPR5242] (ab109429)
Immunohistochemical analysis of Fragilis in paraffin-embedded Human kidney tissue using ab109429 at 1/250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
-
Anti-Fragilis antibody [EPR5242] (ab109429) at 1/1000 dilution +
Recombinant Human Fragilis protein (ab92921) at 0.01 µg
Secondary
Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (ab97080) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 15 kDa
Exposure time: 10 seconds
プロトコール
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (21)
ab109429 は 21 報の論文で使用されています。
- Degrelle SA et al. IFITM1 inhibits trophoblast invasion and is induced in placentas associated with IFN-mediated pregnancy diseases. iScience 26:107147 (2023). PubMed: 37434700
- Verma S et al. IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters. Viruses 15:N/A (2023). PubMed: 38140631
- Liang G et al. Identification of differentially expressed and methylated genes and construction of a co-expression network in age-related macular degeneration. Ann Transl Med 10:223 (2022). PubMed: 35280389
- Rahman K et al. Cholesterol Binds the Amphipathic Helix of IFITM3 and Regulates Antiviral Activity. J Mol Biol 434:167759 (2022). PubMed: 35872070
- Shi G et al. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv N/A:N/A (2021). PubMed: 33880473